| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Jazz Pharmaceuticals Plc (JAZZ) has 19 insiders with recent SEC Form 4 filings, including 0 buys and 20 sells. JAZZ is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.18M | $267.27M | - | |
| Dir | 390.7K | $88.26M | - | |
| CEO | 152.2K | $34.38M | - | |
| VP | 72.6K | $16.41M | - | |
| CFO | 59.6K | $13.47M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 6, 2018 | Young Matthew P. | EVP &CFO | Sell | 1,152 | $142.36 | $163,998.29 | -1.4% | |
| Mar 2, 2018 | Treacy Paul | SVP, Technical Operations | Sell | 877 | $139.62 | $122,446.42 | -2.2% | |
| Feb 28, 2018 | Cozadd Bruce C59 | Chairman &CEO | Sell | 1,000 | $150.00 | $150,000.00 | -0.4% | |
| Feb 28, 2018 | Young Matthew P. | EVP &CFO | Sell | 3,135 | $146.85 | $460,380.54 | -1.3% | |
| Feb 14, 2018 | Miller Michael Patrick46 | EVP, Us Commercial | Sell | 200 | $139.99 | $27,998.00 | -0.9% | |
| Jan 16, 2018 | Young Matthew P. | EVP &CFO | Sell | 700 | $152.16 | $106,512.00 | -1.8% | |
| Jan 12, 2018 | Miller Michael Patrick46 | EVP, Us Commercial | Sell | 200 | $148.65 | $29,730.00 | -0.9% | |
| Jan 12, 2018 | Cozadd Bruce C59 | Chairman &CEO | Sell | 3,000 | $150.00 | $450,000.00 | -1.1% | |
| Dec 11, 2017 | Miller Michael Patrick46 | EVP, Us Commercial | Sell | 200 | $139.15 | $27,830.00 | -0.9% | |
| Dec 11, 2017 | Enright Patrick G74 | Director | Sale+OE | 9,000 | $139.73 | $1,257,581.52 | -13.0% |